Marker Therapeutics (MRKR) Change in Account Payables (2014 - 2015)
Marker Therapeutics (MRKR) reported Change in Account Payables of -$2000.0 for Q4 2015, down 100.12% year-over-year from $1.7 million in Q4 2014, and up 99.03% quarter-over-quarter from -$207000.0 in Q3 2015.
Marker Therapeutics (MRKR) Change in Account Payables (2014 - 2015) Analysis & Trends
Marker Therapeutics (MRKR) has 2 years of Change in Account Payables data on file, last reported at -$2000.0 in Q4 2015.
- Change in Account Payables for Q4 2015 came in at -$2000.0, down 100.12% year-over-year; the trailing twelve-month figure through Dec 2015 was $22000.0 (down 99.09% YoY), and the FY2015 annual result was $22000.0, down 99.09% from the prior year.
- Change in Account Payables climbed to -$2000.0 in Q4 2015 per MRKR's latest filing, from -$207000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.7 million in Q4 2014 and troughed at -$207000.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -9.42 Mn |
| 10 | Marker Therapeutics | 27.04 Mn | 27.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -2,000.00 |
| Dec 31, 2015 | -2,000.00 |
| Sep 30, 2015 | -207,000.00 |
| Sep 30, 2015 | -207,000.00 |
| Jun 30, 2015 | 231,000.00 |
| Jun 30, 2015 | 231,000.00 |
| Dec 31, 2014 | 1.73 Mn |
| Dec 31, 2014 | 1.73 Mn |
| Sep 30, 2014 | 314,000.00 |
| Sep 30, 2014 | 314,000.00 |
| Mar 31, 2014 | 369,000.00 |
| Mar 31, 2014 | 369,000.00 |